Retraction Note: J Exp Clin Cancer Res 38, 104 (2019)
https://doi.org/10.1186/s13046-019-1098-y
The Editor-in-Chief has retracted this Article. After publication, concerns were raised regarding overlapping panels in Figs. 6d and 7c. The authors addressed this by publishing a Correction [1]. However, further overlap was subsequently identified in Fig. 2g. The authors have provided the raw data, which has confirmed that a number of the original images were mislabeled. Additionally, the same western blot loading controls are used for different cells and treatment groups in Figs. 2d and 4a.
The Editor-in-Chief therefore no longer has confidence in the presented data.
None of the authors have responded to any correspondence from the publisher about this retraction notice.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Juntao Sun and Tianyu Zhang contributed equally to this work.
Contributor Information
Lei Wang, Email: raylwang@hotmail.com.
Jie Zhong, Email: Jimmyzj64@hotmail.com.
Reference
- 1.Sun J, Zhang T, Cheng M, et al. Correction to: TRIM29 facilitates the epithelial-tomesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway. J Exp Clin Cancer Res. 2021;40:145. doi: 10.1186/s13046-021-01922-w. [DOI] [PMC free article] [PubMed] [Google Scholar]